Efalizumab: differenze tra le versioni
Vai alla navigazione
Vai alla ricerca
Contenuto cancellato Contenuto aggiunto
ins. bibl. |
|||
| Riga 49: | Riga 49: | ||
== Bibliografia == |
== Bibliografia == |
||
* {{cita libro | cognome= British national formulary| nome= | coautori=| titolo= Guida all’uso dei farmaci 4 edizione | editore= agenzia italiana del farmaco | città= Lavis | anno= 2007 | id= }} |
* {{cita libro | cognome= British national formulary| nome= | coautori=| titolo= Guida all’uso dei farmaci 4 edizione | editore= agenzia italiana del farmaco | città= Lavis | anno= 2007 | id= }} |
||
* {{cite book|author=Frank Ashall|title=Le grandi scoperte scientifiche|url=http://books.google.com/books?id=GXsecqAh6MEC&pg=PA245|accessdate=|year=1999|publisher=Armando Editore|isbn=9788871449494|pages=245–}} |
|||
* {{cite book|author1=Abul K. Abbas|author2=Andrew H. Lichtman|author3=Shiv Pillai|title=Immunologia cellulare e molecolare|url=http://books.google.com/books?id=9SFm3nMO_gUC&pg=PA79|accessdate= |year=2010|publisher=Elsevier srl|isbn=9788821431760|pages=79–}} |
|||
* {{cite book|author1=Abul K. Abbas|author2=Andrew H. Lichtman|title=Le basi dell'immunologia|url=http://books.google.com/books?id=szHkdI9buskC&pg=PA70|accessdate|year=2006|publisher=Elsevier srl|isbn=9788885675858|pages=70–}} |
|||
* {{cite book|author1=Humphrey P. Rang|author2=M. Maureen Dale|author3=James M. Ritter|title=Farmacologia|url=http://books.google.com/books?id=HGcP_ip4SmgC&pg=PA778|accessdate|year=2008|publisher=Elsevier srl|isbn=9788821430237|pages=778–}} |
|||
* {{cite book|author=Enzo Fagiolo|title=Immunoematologia|url=http://books.google.com/books?id=ErRtMU7SKhkC&pg=PA16|accessdate=|year=2007|publisher=Mediserve s.r.l.|isbn=9788882041359|pages=16–}} |
|||
* {{cite book|author=Paolo Larizza|title=Trattato di medicina interna|url=http://books.google.com/books?id=Rt4_C55_Ls4C&pg=PA909|accessdate=|year=2005|publisher=PICCIN|isbn=9788829917211|pages=909–}} |
|||
* {{cite book|author=Angelo Sghirlanzoni|title=Terapia Delle Malattie Neurologiche|url=http://books.google.com/books?id=LCNUGXlL4FQC&pg=PA113|accessdate= |date=3 April 2010|publisher=Springer|isbn=9788847011199|pages=113–}} |
|||
* {{cite book|author=Thomas C. King|title=Patologia|url=http://books.google.com/books?id=1CgV-Td_I3oC&pg=PA156|accessdate= |year=2008|publisher=Elsevier srl|isbn=9788821430190|pages=156–}} |
|||
* {{en}}{{cite book|author=Marie A. Simmons|title=Monoclonal antibodies: new research|url=http://books.google.com/books?id=jxhKskARw6IC|accessdate=|year=2005|publisher=Nova Publishers|isbn=9781594542473}} |
|||
* {{en}}{{cite book|author=Zhiqiang An|title=Therapeutic Monoclonal Antibodies: From Bench to Clinic|url=http://books.google.com/books?id=agdx2rtK7E0C|accessdate= |date=8 September 2009|publisher=John Wiley and Sons|isbn=9780470117910}} |
|||
* {{en}}{{cite book|author=James W. Goding|title=Monoclonal antibodies: principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology|url=http://books.google.com/books?id=jPk4ZY4CnQQC|accessdate=|year=1996|publisher=Academic Press|isbn=9780122870231}} |
|||
* {{en}}{{cite book|author=Steve Shire|title=Current Trends in Monoclonal Antibody Development and Manufacturing|url=http://books.google.com/books?id=YTbJpdPhgT4C|accessdate= |date=April 2009|publisher=Springer|isbn=9780387766423}} |
|||
=== Efalizumab === |
|||
* {{en}}{{cite book|author=Stefan Dübel|title=Handbook of therapeutic antibodies: Approved therapeutics|url=http://books.google.com/books?id=ByHccWJfuhMC&pg=PA834|accessdate=|date=26 March 2007|publisher=Wiley-VCH|isbn=9783527314539|pages=834–}} |
|||
* {{en}}{{cite book|author=Bernd Meibohm|title=Pharmacokinetics and pharmacodynamics of biotech drugs: principles and case studies in drug development|url=http://books.google.com/books?id=XEaxH8ZRjFIC&pg=PA316|accessdate=|year=2006|publisher=Wiley-VCH|isbn=9783527314089|pages=316–}} |
|||
* {{en}}{{cite book|author1=Helen Liapis|author2=Hanlin Wang|author3=Jon H. Ritter|title=Pathology of Solid Organ Transplantation|url=http://books.google.com/books?id=lTE8qf3aiowC&pg=PA24|accessdate=|date=7 January 2011|publisher=Springer|isbn=9783540793427|pages=24–}} |
|||
* {{en}}{{cite book|author=Yoshiki Miyachi|title=Therapy of Skin Diseases|url=http://books.google.com/books?id=jFurh7g1Uz8C&pg=PA31|accessdate=27 March 2011|date=3 November 2009|publisher=Springer|isbn=9783540788133|pages=31–}} |
|||
== Voci correlate == |
== Voci correlate == |
||
Versione delle 11:18, 27 mar 2011
Template:Disclaimer medico Template:Farmaco
L’ efalizumab è il nome del principio attivo che influenza la risposta immunitaria dell’individuo, viene utilizzato per combattere le reazione della cute anomale in forma grave quali eczema e psoriasi. Tale farmaco viene somministrato quasi esclusivamente a persone ricoverate
Indicazioni
Viene utilizzato come terapia contro la psoriasi, quando gli altri medicinali non hanno fornito gli effetti desiderati
Controindicazioni
Da evitare in caso di piastrinopenia, e anche se la persona soffre di insufficienza renale ed epatica, si sconsiglia l’uso in caso di gravidanza e allattamento.
Dosaggi
- per iniezione sottocutanea 700 ug/kg da aumentare in seguito a 1 mg
Effetti indesiderati
Fra gli effetti indesiderati si ritrovano astenia, leucocitosi, trombocitopenia, artralgia, encefalopatia progressiva multifocale.
Bibliografia
- British national formulary, Guida all’uso dei farmaci 4 edizione, Lavis, agenzia italiana del farmaco, 2007.
- Frank Ashall, Le grandi scoperte scientifiche, Armando Editore, 1999, pp. 245–, ISBN 9788871449494.
- Immunologia cellulare e molecolare, Elsevier srl, 2010, pp. 79–, ISBN 9788821431760.
- Le basi dell'immunologia, Elsevier srl, 2006, pp. 70–, ISBN 9788885675858.
- Farmacologia, Elsevier srl, 2008, pp. 778–, ISBN 9788821430237.
- Enzo Fagiolo, Immunoematologia, Mediserve s.r.l., 2007, pp. 16–, ISBN 9788882041359.
- Paolo Larizza, Trattato di medicina interna, PICCIN, 2005, pp. 909–, ISBN 9788829917211.
- Angelo Sghirlanzoni, Terapia Delle Malattie Neurologiche, Springer, 3 April 2010, pp. 113–, ISBN 9788847011199.
- Thomas C. King, Patologia, Elsevier srl, 2008, pp. 156–, ISBN 9788821430190.
- (EN) Marie A. Simmons, Monoclonal antibodies: new research, Nova Publishers, 2005, ISBN 9781594542473.
- (EN) Zhiqiang An, Therapeutic Monoclonal Antibodies: From Bench to Clinic, John Wiley and Sons, 8 September 2009, ISBN 9780470117910.
- (EN) James W. Goding, Monoclonal antibodies: principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology, Academic Press, 1996, ISBN 9780122870231.
- (EN) Steve Shire, Current Trends in Monoclonal Antibody Development and Manufacturing, Springer, April 2009, ISBN 9780387766423.
Efalizumab
- (EN) Stefan Dübel, Handbook of therapeutic antibodies: Approved therapeutics, Wiley-VCH, 26 March 2007, pp. 834–, ISBN 9783527314539.
- (EN) Bernd Meibohm, Pharmacokinetics and pharmacodynamics of biotech drugs: principles and case studies in drug development, Wiley-VCH, 2006, pp. 316–, ISBN 9783527314089.
- (EN) Pathology of Solid Organ Transplantation, Springer, 7 January 2011, pp. 24–, ISBN 9783540793427.
- (EN) Yoshiki Miyachi, Therapy of Skin Diseases, Springer, 3 November 2009, pp. 31–, ISBN 9783540788133. URL consultato il 27 March 2011.
